Consistent with a tumor‐promoting role for LAMs in breast cancer, others have demonstrated that the depletion of LAMs with clodronate in an EMT6 model of murine breast cancer results in decreased tumor burden. This evidence concerns the gene LAMB2 and breast cancer.